Search, analyze & compare

My selected companies

Adjust valuation method
WatchlistNameTickerP/EP/SP/BEV/EbitdaROEROICRSISMA200DCFVolumeClosing price
-
Tilray IncTLRY-7.111.810.4151.56-6.57%-0.81%61.14$1.71$1.90317,827$1.72

Detail of Tilray Inc

 
CEO
Mr. Irwin David Simon
Employees
2650
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Market cap
$1B

Company details

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Beverage Alcohol, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. The company offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Charlotte's Web, Montauk Brewing, Shock Top, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point Brewing, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Bake Sale, The Batch, HEXO, Alpine Beer Company, Green Flash, Hiball Energy, Redhook Brewery, Square Mile Cider, Widmer Brothers Brewing, Runner's High Brewing Company, Happy Flower, and Fresh Hemp Foods brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$788.94M
Cost of goods (CoG)
-$565.59M
Gross profit (GP)
$223.35M
Operating expense (OE)
-$251.36M
Research and development (R&D)
-$635,000.00
General and administrative (G&A)
-$250.72M
Operating income (OI)
-$112.76M
Other income expense (OIE)
-$99.83M
Pretax income (PI)
-$249.02M
Tax (TAX)
$26.62M
Net income (NI)
-$222.40M
Tilray Inc
TLRY • XNGS • US
$1.72
-0.01 (-0.29%)
Stock vs Industry average
  • Industry average

Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$0.24
Margin profit
-31.05%
52 week low
$1.555
52 week high
$2.85
50-day simple moving average
$1.70
200-day simple moving average
$1.71
Percent held by insiders
1.42%
Percent held by institutions
11.47%
Dividend yield
0.00%

Change of shares

Cash vs Debt

Insider Trading

Comparison of selected companies

 
%
Price change
TLRY -3.91%
eps change
TLRY 0.00%